Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Phase 1
54
about 7.1 years
18+
1 site in IL
What this study is about
Researchers are testing the safety of a treatment combining irinotecan with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel. The trial will involve adults who have adenocarcinoma, gastroesophageal junction adenocarcinoma, or pancreatic adenocarcinoma.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 5-Fluorouracil
- 2.Take Docetaxel
- 3.Take Irinotecan
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluorouracil (Antimetabolite; mimics uracil to disrupt DNA/RNA in cancer cells), docetaxel, irinotecan, Antidotes, Deterrents, and Toxicologic Agents (Enzyme Interactions), oxaliplatin
infusion, injection (Injection)
Secondary: Overall Response Rate, Overall survival rate, Progression free survival rate